Subscribe to our Email Alerts

Island Pharmaceuticals
  • About Us
    • Island at a glance
    • Board
    • Key Management
    • Scientific Advisory Board
    • Collaborations
  • Science
    • About ISLA-101
    • Scientific Publications
    • Drug repurposing and benefits
    • Disease and drug terms explained
  • Investor Centre
    • Investor Welcome
      • Clinical programme
    • ASX Announcements
    • Presentations
    • Prospectus
    • Financial Reports
    • Share Price Information
    • Shareholder Services
    • Investor Fact Sheet
    • Corporate Governance
    • Corporate Directory
    • International Investors
    • Research Coverage
    • AGM
  • Media
    • News
    • IslandWatch Newsletter
  • Contact
    • Contact Us
    • Subscribe for Email Alerts
Media
Media > News
  • News
  • IslandWatch Newsletter

News

Filter by Year:2025 2024 2023 2022 2021 2020 
4-Oct-2024
Island Pharmaceuticals doses subjects in dengue fever trial, enters final phase for 2024 results
3-Oct-2024
The Australian: Island lifts 50pc on $3.5m capital raise and Phase 2a/b dengue trial progress
3-Oct-2024
ausbiz: The small cap itching closer to stopping dengue's spread
3-Oct-2024
VIDEO: Professor Stephen Thomas discusses the challenges and opportunities with dengue research
3-Oct-2024
VIDEO: Island CEO on major milestones: subjects dosed in dengue trial & $3.5M Placement
27-Aug-2024
Stockhead: Island announces US Army IRB approval, commences subject screening for Phase 2a/b trial
7-Aug-2024
Proactive: Island announces clinical updates for Phase 2a/b challenge study
7-Aug-2024
Island Pharmaceuticals progresses dengue fever Phase 2a/b clinical trial with US FDA approvals
14-Jun-2024
Dr Boreham’s Crucible: Island Pharmaceuticals
12-Jun-2024
Video with Dr David Foster regarding Piggy Back Options deadline
  • Previous 
  • 1
  • 2
  • 3
  • 4
  •  Next

NOTICE

It has come to the company's attention that unauthorised individuals may be falsely claiming to represent Island Pharmaceuticals Limited in employment offers and recruitment communications. Please be advised that all legitimate employment opportunities are advertised through official company channels, the company's social media channels and via authorised recruitment partners.

Island Pharmaceuticals Limited will never request payment, personal financial information, or conduct interviews via unofficial platforms. If you receive a suspicious message or offer, please report it to us immediately at henry.jordan@sdir.com.au

Your safety and security are important to us.

Kind regards,
Island Pharmaceuticals Limited

Quick Links

Contact Us

Island Pharmaceuticals
Suite 201, 697 Burke Road
Camberwell, Victoria 3124

info@islandpharmaceuticals.com

www.islandpharmaceuticals.com

Email Alerts

Which of the following group do you best fit?

 

Follow Us

Follow Us

Site Map Privacy Search
Copyright © Island Pharmaceuticals
Site Map Privacy Search
Site by